HeiQ raises €9.7M Growth round
6 December 2024· Zurich, Switzerland· manufacturing, biotech, materials, b2b, software_hardware
The funding is intended to strengthen HeiQ's financial position, provide an opportunity for shareholders to increase their investment, and enable the company to fund and scale its portfolio of breakthrough technologies, including HeiQ Synbio™, HeiQ AeoniQ™, HeiQ GrapheneX™, and HeiQ Xpectra™.
Investors
LeadDarren Morcombe
Also participating
Pierre LassondeThomas R. F. DunnValentin DoronichevCarlo Centonze
About HeiQ
Stage
Growth
Headquarters
Zurich, Switzerland
Founded
2005
Team Size
201–500
Sectors
manufacturingbiotechmaterialsb2bsoftware_hardware